Sharifi N - Search Results

1

5-Hydroxyeicosatetraenoic Acid Controls Androgen Reduction in Diverse Types of Human Epithelial Cells.

Hardaway AL, Goudarzi M, Berk M, Chung YM, Zhang R, Li J, Klein E, Sharifi N. Hardaway AL, et al. Among authors: sharifi n. Endocrinology. 2022 Nov 14;164(1):bqac191. doi: 10.1210/endocr/bqac191. Endocrinology. 2022. PMID: 36412122 Free PMC article.

2

3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.

Evaul K, Li R, Papari-Zareei M, Auchus RJ, Sharifi N. Evaul K, et al. Among authors: sharifi n. Endocrinology. 2010 Aug;151(8):3514-20. doi: 10.1210/en.2010-0138. Epub 2010 Jun 9. Endocrinology. 2010. PMID: 20534728

3

Minireview: Androgen metabolism in castration-resistant prostate cancer.

Sharifi N. Sharifi N. Mol Endocrinol. 2013 May;27(5):708-14. doi: 10.1210/me.2013-1007. Epub 2013 Apr 16. Mol Endocrinol. 2013. PMID: 23592429 Free PMC article. Review.

4

Mechanisms of androgen receptor activation in castration-resistant prostate cancer.

Sharifi N. Sharifi N. Endocrinology. 2013 Nov;154(11):4010-7. doi: 10.1210/en.2013-1466. Epub 2013 Sep 3. Endocrinology. 2013. PMID: 24002034 Free PMC article. Review.

5

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.

Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N. Li Z, et al. Among authors: sharifi n. Nature. 2016 May 26;533(7604):547-51. doi: 10.1038/nature17954. Nature. 2016. PMID: 27225130 Free PMC article.

6

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.

Hearn JWD, AbuAli G, Reichard CA, Reddy CA, Magi-Galluzzi C, Chang KH, Carlson R, Rangel L, Reagan K, Davis BJ, Karnes RJ, Kohli M, Tindall D, Klein EA, Sharifi N. Hearn JWD, et al. Among authors: sharifi n. Lancet Oncol. 2016 Oct;17(10):1435-1444. doi: 10.1016/S1470-2045(16)30227-3. Epub 2016 Aug 27. Lancet Oncol. 2016. PMID: 27575027 Free PMC article.

7

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.

Li J, Alyamani M, Zhang A, Chang KH, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin ME, Garcia JA, Courtney K, Klein EA, Sharifi N. Li J, et al. Among authors: sharifi n. Elife. 2017 Feb 13;6:e20183. doi: 10.7554/eLife.20183. Elife. 2017. PMID: 28191869 Free PMC article.

8

Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities.

Alyamani M, Li Z, Berk M, Li J, Tang J, Upadhyay S, Auchus RJ, Sharifi N. Alyamani M, et al. Among authors: sharifi n. Cell Chem Biol. 2017 Jul 20;24(7):825-832.e6. doi: 10.1016/j.chembiol.2017.05.020. Epub 2017 Jun 22. Cell Chem Biol. 2017. PMID: 28648378 Free PMC article.

9

Direct Metabolic Interrogation of Dihydrotestosterone Biosynthesis from Adrenal Precursors in Primary Prostatectomy Tissues.

Dai C, Chung YM, Kovac E, Zhu Z, Li J, Magi-Galluzzi C, Stephenson AJ, Klein EA, Sharifi N. Dai C, et al. Among authors: sharifi n. Clin Cancer Res. 2017 Oct 15;23(20):6351-6362. doi: 10.1158/1078-0432.CCR-17-1313. Epub 2017 Jul 21. Clin Cancer Res. 2017. PMID: 28733443 Free PMC article.

10

Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer.

Ko HK, Berk M, Chung YM, Willard B, Bareja R, Rubin M, Sboner A, Sharifi N. Ko HK, et al. Among authors: sharifi n. Cell Rep. 2018 Jan 16;22(3):809-819. doi: 10.1016/j.celrep.2017.12.081. Cell Rep. 2018. PMID: 29346776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page